Here, we are going to share Aarti Pharmalabs Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.
Aarti Pharmalabs Limited (APL), founded in 2019, is a well-known Indian company that focuses in active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities (NCEs), and xanthine derivatives.
The company maintains six production units and two R&D centers, three of which are accredited by international regulatory agencies such as the USFDA, EUGMP, EDQM, KFDA, and COFEPRIS.
Aarti Pharmalabs Share Key Information
| Company Name | Aarti Pharmalabs |
| Headquarters | |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 5,861.69 Cr. |
| No. of Shares | 9.06 Cr. |
| Book Value | ₹188.35 |
| Dividend Yield | 0.47% |
| ROCE | 16.55% |
| ROE | 13.11% |
| Face Value | ₹5 |
| Sales Growth | -0.60% |
| Profit Growth | 16.84% |
Aarti Pharmalabs Business Sector
Generic APIs and Intermediates: Supplying high-quality APIs and intermediates to global pharmaceutical companies.
Xanthine Derivatives: Producing compounds like caffeine, utilized in pharmaceuticals and nutraceuticals.
Contract Development and Manufacturing Organization (CDMO) Services: Providing end-to-end solutions from process R&D to commercial production for drug substances and NCEs.
Board Members
- Chandrakant Vallabhaji Gogri: Chairman Emeritus.
- Rashesh C. Gogri: Chairman and Non-Executive Director.
- Hetal Gogri Gala: Vice Chairperson and Managing Director.
- Narendra J. Salvi: Managing Director.
- Rajendra V. Gogri: Non-Executive Director.
- Parimal H. Desai: Non-Executive Director.
- Bhavesh R. Vora: Independent Director.
- Vinay G. Nayak: Independent Director.
- Vilas G. Gaikar: Independent Director.
Aarti Pharmalabs Share Quarterly Results
| PARTICULARS | Jun 2024 (Cr.) | Sep 2024 (Cr.) |
|---|---|---|
| Net Sales | 393.49 | 377.29 |
| Total Expenditure | 309.83 | 292.52 |
| Operating Profit | 83.66 | 84.77 |
| Other Income | 2.11 | 2.95 |
| Interest | 4.25 | 5.39 |
| Depreciation | 18.29 | 18.89 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 63.23 | 63.43 |
| Tax | 16.08 | 15.60 |
| Profit After Tax | 47.14 | 47.84 |
| Adjusted EPS (Rs) | 5.20 | 5.28 |
Aarti Pharmalabs Company Profits and Losses
| PARTICULARS | Mar 2023 (Cr.) | Mar 2024 (Cr.) |
|---|---|---|
| Net Sales | 1,511.25 | 1,502.13 |
| Total Expenditure | 1,202.91 | 1,155.97 |
| Operating Profit | 308.34 | 346.16 |
| Other Income | 1.28 | 11.01 |
| Interest | 20.49 | 16.63 |
| Depreciation | 55.77 | 66.01 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 233.36 | 274.52 |
| Tax | 61.63 | 73.87 |
| Net Profit | 171.73 | 200.65 |
| Adjusted EPS (Rs.) | 18.95 | 22.14 |
Aarti Pharmalabs Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹692 | ₹824 |
| 2026 | ₹838 | ₹972 |
| 2027 | ₹983 | ₹1118 |
| 2028 | ₹1129 | ₹1263 |
| 2029 | ₹1275 | ₹1401 |
| 2030 | ₹1410 | ₹1265 |
| 2035 | ₹2120 | ₹2450 |
| 2040 | ₹3210 | ₹3600 |
Aarti Pharmalabs Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹692 |
| February 2025 | ₹703 |
| March 2025 | ₹715 |
| April 2025 | ₹726 |
| May 2025 | ₹740 |
| June 2025 | ₹751 |
| July 2025 | ₹765 |
| August 2025 | ₹776 |
| September 2025 | ₹787 |
| October 2025 | ₹801 |
| November 2025 | ₹813 |
| December 2025 | ₹824 |
Based on the 2025 forecast, the initial target of Aarti Pharmalabs share can could be ₹692 and by the end of the year, the share price target is estimated to reach ₹824.
Aarti Pharmalabs Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹838 |
| February 2026 | ₹849 |
| March 2026 | ₹860 |
| April 2026 | ₹874 |
| May 2026 | ₹885 |
| June 2026 | ₹897 |
| July 2026 | ₹911 |
| August 2026 | ₹922 |
| September 2026 | ₹933 |
| October 2026 | ₹947 |
| November 2026 | ₹958 |
| December 2026 | ₹972 |
Based on the 2026 forecast, the initial target of Aarti Pharmalabs share can could be ₹838 and by the end of the year, the share price target is estimated to reach ₹972.
Aarti Pharmalabs Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹983 |
| February 2027 | ₹995 |
| March 2027 | ₹1005 |
| April 2027 | ₹4020 |
| May 2027 | ₹1031 |
| June 2027 | ₹1042 |
| July 2027 | ₹1056 |
| August 2027 | ₹1067 |
| September 2027 | ₹1081 |
| October 2027 | ₹1093 |
| November 2027 | ₹1104 |
| December 2027 | ₹1118 |
Based on the 2027 forecast, the initial target of Aarti Pharmalabs share can could be ₹983 and by the end of the year, the share price target is estimated to reach ₹1118.
Aarti Pharmalabs Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹1129 |
| February 2028 | ₹1140 |
| March 2028 | ₹1154 |
| April 2028 | ₹1165 |
| May 2028 | ₹1177 |
| June 2028 | ₹1191 |
| July 2028 | ₹1202 |
| August 2028 | ₹1216 |
| September 2028 | ₹1227 |
| October 2028 | ₹1238 |
| November 2028 | ₹1252 |
| December 2028 | ₹1263 |
Based on the 2028 forecast, the initial target of Aarti Pharmalabs share can could be ₹1129 and by the end of the year, the share price target is estimated to reach ₹1263.
Aarti Pharmalabs Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹1275 |
| February 2029 | ₹1286 |
| March 2029 | ₹1300 |
| April 2029 | ₹1311 |
| May 2029 | ₹1325 |
| June 2029 | ₹1336 |
| July 2029 | ₹1347 |
| August 2029 | ₹1361 |
| September 2029 | ₹1373 |
| October 2029 | ₹1384 |
| November 2029 | ₹1389 |
| December 2029 | ₹1401 |
Based on the 2029 forecast, the initial target of Aarti Pharmalabs share can could be ₹1275 and by the end of the year, the share price target is estimated to reach ₹1401.
Aarti Pharmalabs Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹1410 |
| February 2030 | ₹1425 |
| March 2030 | ₹1443 |
| April 2030 | ₹1456 |
| May 2030 | ₹1448 |
| June 2030 | ₹1465 |
| July 2030 | ₹1479 |
| August 2030 | ₹1495 |
| September 2030 | ₹1505 |
| October 2030 | ₹1532 |
| November 2030 | ₹1549 |
| December 2030 | ₹1565 |
Based on the 2030 forecast, the initial target of Aarti Pharmalabs share can could be ₹1410 and by the end of the year, the share price target is estimated to reach ₹1565.
Aarti Pharmalabs Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹2120 |
| April 2035 | ₹2190 |
| July 2035 | ₹2270 |
| October 2035 | ₹2340 |
| December 2035 | ₹2450 |
Based on the 2035 forecast, the initial target of Aarti Pharmalabs share can could be ₹2120 and by the end of the year, the share price target is estimated to reach ₹2450.
Aarti Pharmalabs Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹3210 |
| April 2040 | ₹3298 |
| July 2040 | ₹3375 |
| October 2040 | ₹3480 |
| December 2040 | ₹3600 |
Based on the 2040 forecast, the initial target of Aarti Pharmalabs share can could be ₹3210 and by the end of the year, the share price target is estimated to reach ₹3600.
Aarti Pharmalabs Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 46.10% |
| FIIs | 7.38% |
| DIIs | 11.36% |
| Others | 0% |
| Public | 35.16% |
Aarti Pharmalabs Company Competitors
- AMI Organics
- Orchid Pharma
- Unichem Lab
- Hikal Ltd
- Supriya Lifescience
Bull Case of Aarti Pharmalabs (Reasons to Invest)
- Diverse Portfolio: Wide range of APIs and intermediates reduces market dependency.
- Global Compliance: Accreditations from USFDA, EUGMP, etc., enable global operations.
- Strong R&D: Focus on innovation drives growth in NCEs and custom manufacturing.
Bear Case of Aarti Pharmalabs (Risks Involved)
- Intense Competition: High competition in pharmaceutical manufacturing.
- Regulatory Costs: Stringent compliance increases operational expenses.
- Raw Material Volatility: Price fluctuations can impact margins.
Aarti Pharmalabs Share Price Target: FAQ
What will be the target of Aarti Pharmalabs Share for the year 2025?
By the end of the year 2025, its share price can reach ₹824.
What will be the target of Aarti Pharmalabs Share for the year 2026?
By the end of the year 2026, its share price can reach ₹972.
What will be the target of Aarti Pharmalabs Share for the year 2027?
By the end of the year 2027, its share price can reach ₹1118.
What will be the target of Aarti Pharmalabs Share for the year 2028?
By the end of the year 2028, its share price can reach ₹1263.
What will be the target of Aarti Pharmalabs Share for the year 2029?
By the end of the year 2029, its share price can reach ₹1401.
What will be the target of Aarti Pharmalabs Share for the year 2030?
By the end of the year 2030 its share price can reach ₹1565.
What is the Current market cap of Aarti Pharmalabs company?
At present the market cap of this company is ₹ 5,861.69 Cr.
What is the NSE symbol of Aarti Pharmalabs company?
The symbol of this company in NSE exchange is AARTIPHARM.
What is the BSE symbol of Aarti Pharmalabs company?
The symbol of this company in BSE exchange is 543748.
Read also:
Tera Software Share Price Target 2025 to 2040, Detailed Analysis
Aditya Vision Share Price Target 2025 to 2040, Detailed Analysis
PPAP Automotive Share Price Target 2025 to 2040, Detailed Analysis
